Diagnosis and classification of Goodpasture's disease (anti-GBM)

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 108-112

  Hellmark, Thomas ^a   Segelmark, Mårten ^b  

^a LUND UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Anti GBM disease; Autoantibodies; Glomerulonephritis; Goodpasture's disease; Vasculitis

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; ENVIRONMENTAL CHEMICAL; GLUCOCORTICOID; HLA DRB1 ANTIGEN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AWARENESS; CIRCULATION; CLINICAL FEATURE; DISEASE SEVERITY; FOLLOW UP; GENETIC LINKAGE; GENETICS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GOODPASTURE SYNDROME; HUMAN; KIDNEY FUNCTION; LUNG ALVEOLITIS; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SMALL VESSEL VASCULITIS; SURVIVAL RATE;

ANTI-GBM DISEASE; AUTOANTIBODIES; GLOMERULONEPHRITIS; GOODPASTURE'S DISEASE; VASCULITIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; EARLY DIAGNOSIS; HUMANS; INFLAMMATION; KIDNEY GLOMERULUS; VASCULITIS;

EID: 84895875154     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.024     Document Type: Article

References (36)

1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
2. Stanton M.C., Tange J.D. Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Aust Ann Med 1958, 7:132-144.
3. Goodpasture E.W. The significance of certain pulmonary lesions in relations in relation to the etiology of influenza. Am J Med Sci 1919, 158:863-870.
4. Lerner R.A., Glassock R.J., Dixon F.J. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. JExp Med 1967, 126:989-1004.
5. Wieslander J., Bygren P., Heinegard D. Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci U S A 1984, 81:1544-1548.
6. Kleppel M.M., Santi P.A., Cameron J.D., Wieslander J., Michael A.F. Human tissue distribution of novel basement membrane collagen. Am J Pathol 1989, 134:813-825.
7. Segelmark M., Hellmark T., Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract 2003, 94:c59-c68.
8. Cui Z., Zhao M.H., Xin G., Wang H.Y. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract 2005, 99:c49-c55.
9. Segelmark M., Dahlberg P., Wieslander J. Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies. Clin Kidney J 2012, 5:549-551.
10. Yang R., Hellmark T., Zhao J., Cui Z., Segelmark M., Zhao M.H., et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009, 24:1838-1844.
11. Wieslander J., Langeveld J., Butkowski R., Jodlowski M., Noelken M., Hudson B.G. Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. JBiol Chem 1985, 260:8564-8570.
12. Hellmark T., Johansson C., Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 1994, 46:823-829.
13. Hellmark T., Segelmark M., Unger C., Burkhardt H., Saus J., Wieslander J. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999, 55:936-944.
14. Hudson B.G., Tryggvason K., Sundaramoorthy M., Neilson E.G. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. NEngl J Med 2003, 348:2543-2556.
15. Hellmark T., Burkhardt H., Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. JBiol Chem 1999, 274:25862-25868.
16. Borza D.B., Bondar O., Colon S., Todd P., Sado Y., Neilson E.G., et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. JBiol Chem 2005, 280:27147-27154.
17. Vanacore R.M., Ham A.J., Cartailler J.P., Sundaramoorthy M., Todd P., Pedchenko V., et al. Arole for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. JBiol Chem 2008, 283:22737-22748.
18. Lou Y.H. Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease?. Arch Immunol Ther Exp (Warsz) 2004, 52:96-103.
19. Bolton W.K., Chen L., Hellmark T., Wieslander J., Fox J.W. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. JAm Soc Nephrol 2005, 16:2657-2666.
20. Yang R., Cui Z., Hellmark T., Segelmark M., Zhao M.H., Wang H.Y. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 2007, 124:207-212.
21. Luo H., Chen M., Cui Z., Yang R., Xu P.C., Zhou X.J., et al. The association of HLA-DQB1, -DQA1 and -DPB1 alleles with anti-glomerular basement membrane (GBM) disease in Chinese patients. BMC Nephrol 2011, 12:21.
22. Salama A.D., Levy J.B., Lightstone L., Pusey C.D. Goodpasture's disease. Lancet 2001, 358:917-920.
23. Taylor D.M., Yehia M., Simpson I.J., Thein H., Chang Y., de Zoysa J.R. Anti-glomerular basement membrane disease in Auckland. Intern Med J 2012, 42:672-676.
24. Savage C.O., Pusey C.D., Bowman C., Rees A.J., Lockwood C.M. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) 1986, 292:301-304.
25. Westman K.W., Ericsson U.B., Hoier-Madsen M., Wieslander J., Lindstedt E., Bygren P.G., et al. Prevalence of autoantibodies associated with glomerulonephritis, unaffected after extracorporeal shock wave lithotripsy for renal calculi, in a three-year follow-up. Scand J Urol Nephrol 1997, 31:463-467.
26. Donaghy M., Rees A.J. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983, 2:1390-1393.
27. Lazor R., Bigay-Game L., Cottin V., Cadranel J., Decaux O., Fellrath J.M., et al. Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore) 2007, 86:181-193.
28. Bowley N.B., Steiner R.E., Chin W.S. The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Clin Radiol 1979, 30:419-429.
29. Harrity P., Gilbert-Barness E., Cabalka A., Hong R., Zimmerman J. Isolated pulmonary Goodpasture syndrome. Pediatr Pathol 1991, 11:635-646.
30. Le Quang C., Delevaux I., Trouillier S., Andre M., Souweine B., Tridon A., et al. [Intra-alveolar haemorrhage without renal damage as the initial presenting feature of Goodpasture's syndrome: case report and review of literature]. Rev Med Interne 2008, 29:1038-1042.
31. Jia X.-y., Hu S.-y., Chen J.-l., Qu Z., Liu G., Cui Z., et al. The clinical and immunological features of patients with combined anti-GBM disease and membranous nephropathy. Kidney Int 2013, [in press]. http://dx.doi.org/10.1038/ki.2013.364.
32. Sinico R.A., Radice A., Corace C., Sabadini E., Bollini B. Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 2006, 21:397-401.
33. Hellmark T., Niles J.L., Collins A.B., McCluskey R.T., Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. JAm Soc Nephrol 1997, 8:376-385.
34. Chen M., Cui Z., Zhao M.H. ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 2010, 25:2062-2065.
35. Ohlsson S., Herlitz H., Lundberg S., Selga D., Mölne J., Wieslander J., et al. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false negative immunoassay test results in anti-GBM disease. Am J Kidney Dis 2013, [in press]. http://dx.doi.org/10.1053/j.ajkd.2013.08.032.
36. Levy J.B., Turner A.N., Rees A.J., Pusey C.D. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134:1033-1042.